EHC — Encompass Health Cashflow Statement
0.000.00%
- $11.42bn
- $14.61bn
- $5.37bn
- 99
- 30
- 97
- 89
Annual cashflow statement for Encompass Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 369 | 517 | 366 | 463 | 597 |
Depreciation | |||||
Deferred Taxes | |||||
Non-Cash Items | 47.8 | 32.2 | 98.8 | 59.7 | 74 |
Discontinued Operations | |||||
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -7.3 | -118 | -30.4 | 50.3 | 21.9 |
Change in Accounts Receivable | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | 705 | 716 | 706 | 851 | 1,003 |
Capital Expenditures | -408 | -551 | -584 | -583 | -643 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Software Development Costs | |||||
Other Investing Cash Flow Items | 0.7 | -115 | -42.9 | -19.7 | -10.8 |
Acquisition of Business | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -408 | -666 | -627 | -603 | -653 |
Financing Cash Flow Items | -235 | -61.4 | 452 | -53.5 | 5.3 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -146 | -240 | -146 | -197 | -331 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 151 | -191 | -66.9 | 50.8 | 18.9 |